Atrial fibrillation: diagnosis and management- Updated guidance (NG196)

Updates include use of tools to calculate risk of bleeding when considering use of anticoagulants, role of newer anti-clotting drugs, and use of treatments that aim to destroy or isolate the abnormal sources of electrical impulses in the heart that may be driving AF (ablation).

SPS commentary:

Press release


National Institute for Health and Care Excellence